Share chart Biomind Labs Inc.
Extended chart
Simple chart
About Biomind Labs Inc.
Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. more details| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.3737 |
| Сайт | https://www.biomindlabs.com |
| Цена ао | 0.7 |
| Change price per day: | 0% (0.7) |
|---|---|
| Change price per week: | 0% (0.7) |
| Change price per month: | 0% (0.7) |
| Change price per 3 month: | 0% (0.7) |
| Change price per half year: | +165.25% (0.2639) |
| Change price per year: | +536.36% (0.11) |
| Change price per 3 year: | -10.14% (0.779) |
| Change price per year to date: | +127.57% (0.3076) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Alejandro Antalich | CEO & Director | 1974 (51 year) | |
| Mr. Oscar Alejandro Leon | CFO & Director | 1960 (65 years) | |
| Ms. Paola Diaz Dellavalle Ph.D. | Chief Scientific Officer | ||
| Mr. Juan Presa | Chief Legal Officer | ||
| Ms. Magdalena Alvarez M.A. | Head of Communication | ||
| Mr. Martin Daners | Head of Quality Assurance & Regulatory Affairs |
Address: Uruguay, Canelones, Building Ceibo Of. 002 - open in Google maps, open in Yandex maps
Website: https://www.biomindlabs.com
Website: https://www.biomindlabs.com
